Journal
PHARMACOLOGY RESEARCH & PERSPECTIVES
Volume 9, Issue 2, Pages -Publisher
JOHN WILEY & SONS LTD
DOI: 10.1002/prp2.724
Keywords
blood-retinal barrier; BNN27; LC-MS; neuroprotection; pharmacokinetics; steroids
Categories
Funding
- Bionature E.A. Ltd
- DINNESMIN [T1EDeltaK - 03186]
- EU
Ask authors/readers for more resources
BNN27, a novel neurosteroid derivative, was detected in the serum and retina of normal rodents after single intraperitoneal administration. Its rapid elimination from the blood and retina, particularly becoming undetectable in the retina after 6 hours, highlights it as a potential neuroprotective agent for retinal disease.
BNN27 is a novel 17-spiroepoxy derivative of the neurosteroid Dehydroepiandrosterone with neuroprotective properties. The purpose of this study was the detection and quantification of BNN27 after single intraperitoneal administration, in the serum and retina of normal rodents. Forty-two C57BL/6 mice and 48 Sprague-Dawley rats were used for the quantification of BNN27 in the blood serum and retina, respectively. BNN27 was injected intraperitoneally (i.p.) at concentrations of 100 and 30 mg/kg of body weight (b.w.), respectively. The blood was collected with retro-orbital bleeding and the retina was isolated after enucleation at various time points. The molecule concentrations were measured with Liquid chromatography-mass spectrometry (LC-MS). Non-compartmental analysis was used to determine pharmacokinetic parameters. BNN27 was found to have an elimination constant k(el) = 0.465 h(-1) and mean residence time (MRT) 2.154 h in the mouse serum. The maximum concentration (C-max) in the retina was detected at 2 h (tCmax) after intraperitoneal administration and was equal to 1100 ng/g. BNN27 is rapidly eliminated from both blood and retina. In the retina specifically, it is undetectable 6 h after injection. BNN27 shows a rapid systemic elimination as anticipated by its small size and lipophilicity. It is measurable in small peripheral tissues such as the rat retina, after one single i.p. injection, using a simple method such as LC-MS. Its detection in the retina corroborates the existing biological data that the molecule crosses the blood-retinal barrier, highlighting it as a potential neuroprotective agent for retinal disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available